Results 11 to 20 of about 330,731 (313)
The Comprehensive Live Cell-Based Cytotoxicity Assay for Monitoring Disease Activity and Guiding Rescue Therapy in Acute Attacks of NMOSD. [PDF]
Ann Clin Transl NeurolABSTRACT Objective Neuromyelitis optica spectrum disorder (NMOSD) is a devastating neurological disease that lacks serological biomarkers that can accurately reflect disease activity. We established a live cell‐based assay (LCBA) using serum with endogenous complement to quantify the overall cytotoxicity, offering a novel functional tool for monitoring
Xu X +10 more
europepmc +2 more sources
Translational Behavioral Medicine, 2010 As the leading public health agency of the U.S. federal government, the CDC is committed to improving the public’s health through practices that are known to make a difference. This commitment is apparent throughout the agency and can be seen clearly in recent activities that aim to prevent and control chronic disease, such as the Communities Putting ...
Nikki A, Hawkins +2 more
openaire +2 more sources
A BARF1-specific mAb as a new immunotherapeutic tool for the management of EBV-related tumors
OncoImmunology, 2017 The use of monoclonal antibodies (mAb) for the diagnosis and treatment of malignancies is acquiring an increasing clinical importance, thanks to their specificity, efficacy and relative easiness of use. However, in the context of Epstein-Barr virus (EBV)-
Riccardo Turrini +10 more
doaj +1 more source
HIV/AIDS: Research and Palliative Care, 2021 Wolde Facha,1 Getahun Molla2 1Department of Epidemiology and Biostatistics, School of Public Health, College of Health Sciences and Medicine, Wolaita Sodo University, Wolaita Sodo, Ethiopia; 2Department of Surgery, School of Medicine, College of Health ...
Facha W, Molla G
doaj
Frontiers in Immunology, 2016 Today monoclonal immunoglobulin gamma (IgG) antibodies have become a major option in cancer therapy especially for the patients with advanced or metastatic cancers.
Abhishek Saxena, Donghui Wu
doaj +1 more source
Long-term mortality trends of COPD and respiratory failure among adults aged ≥25 years in the United States: an analysis of CDC WONDER data (1999-2023). [PDF]
Ann Med Surg (Lond)Affaf Mahmood +2 more
openalex +2 more sources
Frontiers in Clinical Diabetes and HealthcareBackgroundPrediabetes is highly prevalent and significantly increases the risk of type 2 diabetes. While access to proven interventions like the Diabetes Prevention Program (DPP) has historically been limited, digital DPPs (dDPPs) present a promising and
Benjamin Lalani +5 more
doaj +1 more source
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Objective To evaluate the efficacy and safety of ofatumumab in patients with myelin oligodendrocyte glycoprotein antibody–associated disease (MOGAD), and compare it with rituximab. Methods We conducted a single–center, observational study including 22 MOGAD patients treated with ofatumumab and 21 treated with rituximab.
Yuxin Fan +5 more
wiley +1 more source
Journal of Infection and Public Health, 2021 Background: COVID-19 global pandemic is an unprecedented health emergency. Rapid identification and isolation of infected individuals is crucial. Qatar’s National Health Strategic Command Group adopted a cut off 30 for Ct value of RT-PCR result of a ...
Soha Al Bayat +10 more
doaj +1 more source